SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis
A survey-based study analyzed vaccination reactions and disease deterioration after SARS-CoV-2 vaccination among more than 6,000 MS patients in Germany and the United Kingdom.
Read More »A survey-based study analyzed vaccination reactions and disease deterioration after SARS-CoV-2 vaccination among more than 6,000 MS patients in Germany and the United Kingdom.
Read More »